Live Breaking News & Updates on Lodo Therapeutics

Stay updated with breaking news from Lodo therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Lineage Announces Appointment of Charlotte Hubbert, Ph.D., as Vice President of Corporate Development

CARLSBAD, Calif., April 01, 2024 Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced the appointment of veteran industry executive Charlotte Hubbert, Ph.D., as Vice President of Corporate Development. Dr. Hubbert has an extensive background in cell therapy research and venture investment across a broad range of therapeutic modalities and development stages, and has a ....

University Of Washington , United States , Brianm Culley , Charlotte Hubbert , Corporate Development , University Of Washington Innovation Roundtable , Accelerator Corporation , Exchange Commission , Head Of Gates Foundation Venture Capital , Melinda Gates Foundation Strategic Investment Fund , Eterna Therapeutics Inc , Duke University , Roche Group , Vp Corporate Development , Fred Hutch Cancer Institute Evergreen Fund , Institute For Stem Cells , Columbia University , Madrona Venture Group , Kauffman Society Of Fellows , Lineage Cell Therapeutics Inc , Lineage Cell Therapeutics , Vice President , Gates Foundation Venture Capital , Beckman Research Institute , Strategic Director , Madrona Venture ,